AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
ROTATING CHEMOTHERAPY IN THE TREATMENT OF RESISTANT AND OVERTREATED MALIGNANCY - A PRELIMINARY-REPORT
Authors: KOVCIN V MATHE G CICMILSARIC N PONOMAREV D MILINIC N MANDARIC M RADOSAVLJEVIC V DJORDJEVIC M BABIC M
Citation: V. Kovcin et al., ROTATING CHEMOTHERAPY IN THE TREATMENT OF RESISTANT AND OVERTREATED MALIGNANCY - A PRELIMINARY-REPORT, Annals of oncology, 9, 1998, pp. 654-654
THE CELLS ARE MORTAL OR IMMORTAL, DIVIDE AND DISAPPEAR WITH REINCARNATION OR AFTER METABOLIC OR APOPTOTIC DEATH
Authors: MATHE G
Citation: G. Mathe, THE CELLS ARE MORTAL OR IMMORTAL, DIVIDE AND DISAPPEAR WITH REINCARNATION OR AFTER METABOLIC OR APOPTOTIC DEATH, Biomedicine & pharmacotherapy, 52(6), 1998, pp. 241-247
IATROGEN MALE-INFERTILITY
Authors: MATHE G
Citation: G. Mathe, IATROGEN MALE-INFERTILITY, Biomedicine & pharmacotherapy, 52(5), 1998, pp. 193-196
POSSIBLE RESPECT OF PATIENT QUALITY-OF-LIFE - WITHOUT REDUCING SURVIVAL EXPECTANCY - IN BREAST-CANCER-TREATMENT
Authors: MATHE G
Citation: G. Mathe, POSSIBLE RESPECT OF PATIENT QUALITY-OF-LIFE - WITHOUT REDUCING SURVIVAL EXPECTANCY - IN BREAST-CANCER-TREATMENT, Biomedicine & pharmacotherapy, 52(3), 1998, pp. 97-100
LYMPHOCYTES - ATTACKERS AND TARGETS OF THE ONCOGENIC VIRUSES, DEPENDING ON THEIR IMMUNOGENIC STRENGTH
Authors: MATHE G
Citation: G. Mathe, LYMPHOCYTES - ATTACKERS AND TARGETS OF THE ONCOGENIC VIRUSES, DEPENDING ON THEIR IMMUNOGENIC STRENGTH, Biomedicine & pharmacotherapy, 52(1), 1998, pp. 1-5
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
HIGH-RESOLUTION IMAGING MICROELLIPSOMETRY OF SOFT SURFACES AT 3 MU-M LATERAL AND 5 ANGSTROM NORMAL RESOLUTION
Authors: ALBERSDORFER A ELENDER G MATHE G NEUMAIER KR PADUSCHEK P SACKMANN E
Citation: A. Albersdorfer et al., HIGH-RESOLUTION IMAGING MICROELLIPSOMETRY OF SOFT SURFACES AT 3 MU-M LATERAL AND 5 ANGSTROM NORMAL RESOLUTION, Applied physics letters, 72(23), 1998, pp. 2930-2932
HUMAN TUMORS AND HUMAN SPECIFIC VIRUSES
Authors: MATHE G
Citation: G. Mathe, HUMAN TUMORS AND HUMAN SPECIFIC VIRUSES, Biomedicine & pharmacotherapy, 51(6-7), 1997, pp. 241-242
RESTORATION OF AGING REDUCED IMMUNITY IS POSSIBLE WITH IMMUNOMODULATORS AND IS APPLICABLE TO CANCER-TREATMENT AND PREVENTION
Authors: MATHE G FLORENTIN I BRULEYROSSET M
Citation: G. Mathe et al., RESTORATION OF AGING REDUCED IMMUNITY IS POSSIBLE WITH IMMUNOMODULATORS AND IS APPLICABLE TO CANCER-TREATMENT AND PREVENTION, Biomedicine & pharmacotherapy, 51(5), 1997, pp. 193-199
PILOT-STUDY FOR PREOPERATIVE ADMINISTRATION OF L-OHP TO PATIENTS WITHADVANCED SCIRRHOUS TYPE GASTRIC-CANCER
Authors: ERIGUCHI M OSADA I FUJII Y TAKEDA Y YOSHIZAKI I AKIYAMA N YANAGIE H SEKIGUCHI M KIZU R MATSUSHITA H MATHE G
Citation: M. Eriguchi et al., PILOT-STUDY FOR PREOPERATIVE ADMINISTRATION OF L-OHP TO PATIENTS WITHADVANCED SCIRRHOUS TYPE GASTRIC-CANCER, Biomedicine & pharmacotherapy, 51(5), 1997, pp. 217-220
APOPTOSIS - AN IDENTICAL CENTRAL OR COLLATERAL MECHANISM IN THE DEVELOPMENT, FUNCTION AND DEATH OF NEURONS
Authors: MATHE G
Citation: G. Mathe, APOPTOSIS - AN IDENTICAL CENTRAL OR COLLATERAL MECHANISM IN THE DEVELOPMENT, FUNCTION AND DEATH OF NEURONS, Biomedicine & pharmacotherapy, 51(3), 1997, pp. 97-100
IMMUNITY AGING .1. THE CHRONIC PERDURATION OF THE THYMUS ACUTE INVOLUTION AT PUBERTY - OR THE PARTICIPATION OF THE LYMPHOID ORGANS AND CELLS IN FATAL PHYSIOLOGICAL DECLINE
Authors: MATHE G
Citation: G. Mathe, IMMUNITY AGING .1. THE CHRONIC PERDURATION OF THE THYMUS ACUTE INVOLUTION AT PUBERTY - OR THE PARTICIPATION OF THE LYMPHOID ORGANS AND CELLS IN FATAL PHYSIOLOGICAL DECLINE, Biomedicine & pharmacotherapy, 51(2), 1997, pp. 49-57
HYPOTHETICAL REASONS OF THE HIV-1-AIDS TRITHERAPY FAILURE - A CHALLENGING MODEL
Authors: MATHE G
Citation: G. Mathe, HYPOTHETICAL REASONS OF THE HIV-1-AIDS TRITHERAPY FAILURE - A CHALLENGING MODEL, Biomedicine & pharmacotherapy, 51(10), 1997, pp. 413-416
COMBINATIONS OF 3 OR 4 HIV-1 VIROSTATICS APPLIED IN SHORT SEQUENCES WHICH DIFFER FROM EACH OTHER BY DRUG ROTATION - PRELIMINARY-RESULTS OF THE VIRAL LOADS AND CD4 NUMBERS
Authors: MATHE G MORETTE C HALLARD M BLANQUET D
Citation: G. Mathe et al., COMBINATIONS OF 3 OR 4 HIV-1 VIROSTATICS APPLIED IN SHORT SEQUENCES WHICH DIFFER FROM EACH OTHER BY DRUG ROTATION - PRELIMINARY-RESULTS OF THE VIRAL LOADS AND CD4 NUMBERS, Biomedicine & pharmacotherapy, 51(10), 1997, pp. 417-426
IS THE STUDY OF HUMAN CANCER-ASSOCIATED FACTORS, THE BEST OR THE ONLYMODEL FOR HUMAN CARCINOGENESIS RESEARCH .1. THE QUESTION OF HELICOBACTER-PYLORI INFECTION AS AN ACCUSED HUMAN GASTRIC CARCINOGEN
Authors: MATHE G
Citation: G. Mathe, IS THE STUDY OF HUMAN CANCER-ASSOCIATED FACTORS, THE BEST OR THE ONLYMODEL FOR HUMAN CARCINOGENESIS RESEARCH .1. THE QUESTION OF HELICOBACTER-PYLORI INFECTION AS AN ACCUSED HUMAN GASTRIC CARCINOGEN, Biomedicine & pharmacotherapy, 51(1), 1997, pp. 1-4
HYPERTHERMIC EFFECTS ON THE HUMAN METASTATIC LIVER - A TEM STUDY
Authors: BERTONE V BARNI S SILVOTTI MG FREITAS I MATHE G PONTIGGIA P
Citation: V. Bertone et al., HYPERTHERMIC EFFECTS ON THE HUMAN METASTATIC LIVER - A TEM STUDY, Anticancer research, 17(6D), 1997, pp. 4713-4716
DYNAMICS OF GUANOSINE SELF-ASSEMBLED AGGREGATES IN THE HEXAGONAL COLUMNAR PHASE BY QUASI-ELASTIC NEUTRON-SCATTERING
Authors: FRANZ H MATHE G CIUCHI F MARIANI P PETRY W SCHMIDT W
Citation: H. Franz et al., DYNAMICS OF GUANOSINE SELF-ASSEMBLED AGGREGATES IN THE HEXAGONAL COLUMNAR PHASE BY QUASI-ELASTIC NEUTRON-SCATTERING, Molecular crystals and liquid crystals science and technology. Section A, Molecular crystals and liquid crystals, 290, 1996, pp. 155-162
THE MEDIUM CELL SIG(- POSITIVE AND DIFFERENTIAL-DIAGNOSIS WITH OTHER B-LYMPHOBLASTOID NEOPLASIAS(), PROPLASMOCYTIC LYMPHOMA LEUKEMIA )
Authors: MATHE G DIEZCONDE M
Citation: G. Mathe et M. Diezconde, THE MEDIUM CELL SIG(- POSITIVE AND DIFFERENTIAL-DIAGNOSIS WITH OTHER B-LYMPHOBLASTOID NEOPLASIAS(), PROPLASMOCYTIC LYMPHOMA LEUKEMIA ), Biomedicine & pharmacotherapy, 50(9), 1996, pp. 425-432
DOES (ANTI) GROWTH-FACTOR INTERVENTION IN THE MECHANISM SCHEME OF ATHEROMA OFFER US A SYNTHETIC SIMPLIFICATION OR MORE CHAOTIC COMPLEXITY
Authors: MATHE G
Citation: G. Mathe, DOES (ANTI) GROWTH-FACTOR INTERVENTION IN THE MECHANISM SCHEME OF ATHEROMA OFFER US A SYNTHETIC SIMPLIFICATION OR MORE CHAOTIC COMPLEXITY, Biomedicine & pharmacotherapy, 50(6-7), 1996, pp. 233-234
WILL KILLING THE LAST HIV-1 PARTICLE CURE AIDS PATIENTS - DOESNT CMV ACTIVATION AND OR A GRAFT-VERSUS-HOST COMPONENT OF THE DISEASE, ALSO HAVE TO BE CONSIDERED .1. FIRST OF 2 PARTS/
Authors: MATHE G
Citation: G. Mathe, WILL KILLING THE LAST HIV-1 PARTICLE CURE AIDS PATIENTS - DOESNT CMV ACTIVATION AND OR A GRAFT-VERSUS-HOST COMPONENT OF THE DISEASE, ALSO HAVE TO BE CONSIDERED .1. FIRST OF 2 PARTS/, Biomedicine & pharmacotherapy, 50(5), 1996, pp. 185-206
AIDS THERAPY WITH 2, 3 OR 4 AGENT COMBINATIONS, APPLIED IN SHORT SEQUENCES, DIFFERING FROM EACH OTHER BY DRUG ROTATION .1. FIRST OF 2 PARTS- A PHASE-I TRIAL EQUIVALENT, CONCERNING 5 VIROSTATICS - AZT, DDI, DDC, ACRIFLAVINE AND AN ELLIPTICINE ANALOG
Authors: MATHE G PONTIGGIA P ORBACHARBOUYS S TRIANA K AMBETIMA N MORETTE C HALLARD M BLANQUET D
Citation: G. Mathe et al., AIDS THERAPY WITH 2, 3 OR 4 AGENT COMBINATIONS, APPLIED IN SHORT SEQUENCES, DIFFERING FROM EACH OTHER BY DRUG ROTATION .1. FIRST OF 2 PARTS- A PHASE-I TRIAL EQUIVALENT, CONCERNING 5 VIROSTATICS - AZT, DDI, DDC, ACRIFLAVINE AND AN ELLIPTICINE ANALOG, Biomedicine & pharmacotherapy, 50(5), 1996, pp. 220-227
THE LAST REVISED EURO-AMERICAN CLASSIFICATION OF LYMPHOID LEUKEMIAS AND NON-HODGKINS-LYMPHOMAS - THE SAME INACCURACIES AND INCONSISTENCIES IN A CHAOTIC COMPLEXITY
Authors: MATHE G
Citation: G. Mathe, THE LAST REVISED EURO-AMERICAN CLASSIFICATION OF LYMPHOID LEUKEMIAS AND NON-HODGKINS-LYMPHOMAS - THE SAME INACCURACIES AND INCONSISTENCIES IN A CHAOTIC COMPLEXITY, Biomedicine & pharmacotherapy, 50(3-4), 1996, pp. 97-117
LYSOSOMAL EXOCYTOSIS INDUCED BY HYPERTHERMIA - A NEW MODEL OF CANCER DEATH .3. EFFECT ON LIVER METASTASIS
Authors: BARNI S BERTONE V SILVOTTI MG FREITAS I MATHE G PONTIGGIA P
Citation: S. Barni et al., LYSOSOMAL EXOCYTOSIS INDUCED BY HYPERTHERMIA - A NEW MODEL OF CANCER DEATH .3. EFFECT ON LIVER METASTASIS, Biomedicine & pharmacotherapy, 50(2), 1996, pp. 79-84
WILL KILLING THE LAST HIV-1 PARTICLE CURE AIDS PATIENTS.2. DECREASE OF VIRAL LOAD AND OF T-SUPPRESSOR CELLS, AND INCREASE OF THE CYTOTOXIC-CELLS, WITHOUT EFFECT ON CD4, AFTER THE USE OF 10 VIROSTATICS APPLIED IN 3 OR 4 DRUG-COMBINATIONS OF DIFFERENT SEQUENCES - THE TIME FOR CD4 IMMUNOTHERAPY
Authors: MATHE G COLASANTE U MORETTE C HALLARD M BLANQUET D
Citation: G. Mathe et al., WILL KILLING THE LAST HIV-1 PARTICLE CURE AIDS PATIENTS.2. DECREASE OF VIRAL LOAD AND OF T-SUPPRESSOR CELLS, AND INCREASE OF THE CYTOTOXIC-CELLS, WITHOUT EFFECT ON CD4, AFTER THE USE OF 10 VIROSTATICS APPLIED IN 3 OR 4 DRUG-COMBINATIONS OF DIFFERENT SEQUENCES - THE TIME FOR CD4 IMMUNOTHERAPY, Biomedicine & pharmacotherapy, 50(10), 1996, pp. 473-479
LYMPHANGIOGRAPHIC STUDY OF PELVIC ADENOPATHY REGRESSION IN A PHASE-IITRIAL OF METHYL-HYDROXY-ELLIPTICINE IN HIV-1-AIDS COMPLEX
Authors: MATHE G HALLARD M PONTIGGIA P
Citation: G. Mathe et al., LYMPHANGIOGRAPHIC STUDY OF PELVIC ADENOPATHY REGRESSION IN A PHASE-IITRIAL OF METHYL-HYDROXY-ELLIPTICINE IN HIV-1-AIDS COMPLEX, Biomedicine & pharmacotherapy, 50(10), 1996, pp. 510-511
Risultati: 1-25 | 26-50 | 51-58